BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16289367)

  • 1. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): The other face of the coin of histology.
    Ahmed MH
    Med Hypotheses; 2006; 66(3):679-80. PubMed ID: 16289367
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment for NASH: the value of histology.
    Elitsur Y; Lawrence Z; Wang R; Durst PR
    Am J Gastroenterol; 2005 Jan; 100(1):250-1. PubMed ID: 15654810
    [No Abstract]   [Full Text] [Related]  

  • 3. [Non-alcoholic steatohepatitis].
    Alvarez-Martínez H; Pérez-Campos E
    Rev Gastroenterol Mex; 2002; 67(2):118-25. PubMed ID: 12214335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive and non-invasive investigations for non-alcoholic steatohepatitis: the benefit of histology.
    Ahmed MH
    Scand J Gastroenterol; 2005 Oct; 40(10):1260. PubMed ID: 16165706
    [No Abstract]   [Full Text] [Related]  

  • 5. Review article: Drug therapy for non-alcoholic fatty liver disease.
    Comar KM; Sterling RK
    Aliment Pharmacol Ther; 2006 Jan; 23(2):207-15. PubMed ID: 16393299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamins E and C for the treatment of NASH: duplication of results but lack of demonstration of efficacy.
    Adams LA; Angulo P
    Am J Gastroenterol; 2003 Nov; 98(11):2348-50. PubMed ID: 14638333
    [No Abstract]   [Full Text] [Related]  

  • 7. [Alcoholic and non-alcoholic steatohepatitis].
    Dufour JF; Oneta CM
    Ther Umsch; 2004 Aug; 61(8):505-12. PubMed ID: 15457967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of nonalcoholic steatohepatitis (NASH)].
    Nakashima T; Sumida Y; Mitsuyoshi H; Okanoue T
    Nihon Shokakibyo Gakkai Zasshi; 2004 Nov; 101(11):1204-8. PubMed ID: 15570868
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nonalcoholic steatohepatitis (NASH): therapeutic approaches].
    Buscher HP
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S60-2. PubMed ID: 15368170
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis.
    Dufour JF; Oneta CM; Gonvers JJ; Bihl F; Cerny A; Cereda JM; Zala JF; Helbling B; Steuerwald M; Zimmermann A;
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1537-43. PubMed ID: 17162245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-alcoholic steatohepatitis].
    Fehér J
    Orv Hetil; 2002 Aug; 143(32):1875-7. PubMed ID: 12221992
    [No Abstract]   [Full Text] [Related]  

  • 12. [Definition and management of non-alcoholic steatohepatitis (NASH)].
    Hütteroth TH
    Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S64-7. PubMed ID: 11450617
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of vitamin E and C therapy in NASH.
    Harrison SA; Ward JA; Schenker S
    Am J Gastroenterol; 2004 Sep; 99(9):1862. PubMed ID: 15330932
    [No Abstract]   [Full Text] [Related]  

  • 14. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Miele L; Forgione A; Gasbarrini G; Grieco A
    Transl Res; 2007 Mar; 149(3):114-25. PubMed ID: 17320797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of nonalcoholic steatohepatitis: an analytic review.
    Agrawal S; Bonkovsky HL
    J Clin Gastroenterol; 2002 Sep; 35(3):253-61. PubMed ID: 12192203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
    Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic steatohepatitis in children.
    Roberts EA
    Clin Liver Dis; 2007 Feb; 11(1):155-72, x. PubMed ID: 17544977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): the need for biochemical markers.
    Ahmed MH
    Scand J Gastroenterol; 2006 Mar; 41(3):372. PubMed ID: 16497631
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical treatment of non-alcoholic steatohepatitis.
    Kadayifci A; Merriman RB; Bass NM
    Clin Liver Dis; 2007 Feb; 11(1):119-40, ix. PubMed ID: 17544975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic assessment of non-alcoholic fatty liver disease.
    Bondini S; Kleiner DE; Goodman ZD; Gramlich T; Younossi ZM
    Clin Liver Dis; 2007 Feb; 11(1):17-23, vii. PubMed ID: 17544969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.